Bone Marrow Mesenchymal Stem Cell-Derived Dermcidin-Containing Migrasomes enhance LC3-Associated Phagocytosis of Pulmonary Macrophages and Protect against Post-Stroke Pneumonia

被引:34
作者
Li, Tiemei [1 ,2 ]
Su, Xiaotao [1 ]
Lu, Pinglan [3 ]
Kang, Xinmei [1 ]
Hu, Mengyan [1 ,4 ]
Li, Chunyi [1 ]
Wang, Shisi [1 ]
Lu, Danli [1 ]
Shen, Shishi [1 ]
Huang, Huipeng [1 ]
Liu, Yuxin [1 ]
Deng, Xiaohui [1 ]
Cai, Wei [1 ,2 ,3 ]
Wei, Lei [1 ]
Lu, Zhengqi [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Mental & Neurol Dis Res Ctr, Dept Neurol, Guangzhou 510630, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Clin Immunol, Mental & Neurol Dis Res Ctr, Guangzhou 510630, Peoples R China
[3] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou 510630, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 3, Surg Intens Care Unit, Guangzhou 510630, Peoples R China
基金
中国国家自然科学基金;
关键词
bone marrow mesenchymal stem cell; macrophage; migrasome; post-stroke pneumonia; EXTRACELLULAR VESICLES; ISCHEMIC-STROKE; STROMAL CELLS; BRAIN-INJURY; NEUROINFLAMMATION; ANTIBIOTICS; IMPROVES;
D O I
10.1002/advs.202206432
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pneumonia is one of the leading causes of death in patients with acute ischemic stroke (AIS). Antibiotics fail to improve prognosis of patients with post-stroke pneumonia, albeit suppressing infection, due to adverse impacts on the immune system. The current study reports that bone marrow mesenchymal stem cells (BM-MSC) downregulate bacterial load in the lungs of stroke mice models. RNA-sequencing of the lung from BM-MSC-treated stroke models indicates that BM-MSC modulates pulmonary macrophage activities after cerebral ischemia. Mechanistically, BM-MSC promotes the bacterial phagocytosis of pulmonary macrophages through releasing migrasomes, which are migration-dependent extracellular vesicles. With liquid chromatography-tandem mass spectrometry (LC-MS/MS), the result shows that BM-MSC are found to load the antibacterial peptide dermcidin (DCD) in migrasomes upon bacterial stimulation. Besides the antibiotic effect, DCD enhances LC3-associated phagocytosis (LAP) of macrophages, facilitating their bacterial clearance. The data demonstrate that BM-MSC is a promising therapeutic candidate against post-stroke pneumonia, with dual functions of anti-infection and immunol modulation, which is more than a match for antibiotics treatment.
引用
收藏
页数:17
相关论文
empty
未找到相关数据